181 related articles for article (PubMed ID: 34423353)
1. Recent omics-based computational methods for COVID-19 drug discovery and repurposing.
Tayara H; Abdelbaky I; To Chong K
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34423353
[TBL] [Abstract][Full Text] [Related]
2. Application of artificial intelligence and machine learning for COVID-19 drug discovery and vaccine design.
Lv H; Shi L; Berkenpas JW; Dao FY; Zulfiqar H; Ding H; Zhang Y; Yang L; Cao R
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34410360
[TBL] [Abstract][Full Text] [Related]
3. Knowing and combating the enemy: a brief review on SARS-CoV-2 and computational approaches applied to the discovery of drug candidates.
Serafim MSM; Gertrudes JC; Costa DMA; Oliveira PR; Maltarollo VG; Honorio KM
Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33624754
[TBL] [Abstract][Full Text] [Related]
4. Fighting COVID-19 with Artificial Intelligence.
Monteleone S; Kellici TF; Southey M; Bodkin MJ; Heifetz A
Methods Mol Biol; 2022; 2390():103-112. PubMed ID: 34731465
[TBL] [Abstract][Full Text] [Related]
5. Artificial intelligence in COVID-19 drug repurposing.
Zhou Y; Wang F; Tang J; Nussinov R; Cheng F
Lancet Digit Health; 2020 Dec; 2(12):e667-e676. PubMed ID: 32984792
[TBL] [Abstract][Full Text] [Related]
6. Artificial intelligence approach fighting COVID-19 with repurposing drugs.
Ke YY; Peng TT; Yeh TK; Huang WZ; Chang SE; Wu SH; Hung HC; Hsu TA; Lee SJ; Song JS; Lin WH; Chiang TJ; Lin JH; Sytwu HK; Chen CT
Biomed J; 2020 Aug; 43(4):355-362. PubMed ID: 32426387
[TBL] [Abstract][Full Text] [Related]
7. Multi-omics data integration and network-based analysis drives a multiplex drug repurposing approach to a shortlist of candidate drugs against COVID-19.
Tomazou M; Bourdakou MM; Minadakis G; Zachariou M; Oulas A; Karatzas E; Loizidou EM; Kakouri AC; Christodoulou CC; Savva K; Zanti M; Onisiforou A; Afxenti S; Richter J; Christodoulou CG; Kyprianou T; Kolios G; Dietis N; Spyrou GM
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34009288
[TBL] [Abstract][Full Text] [Related]
8. Role of ACE2 receptor and the landscape of treatment options from convalescent plasma therapy to the drug repurposing in COVID-19.
Kumar P; Sah AK; Tripathi G; Kashyap A; Tripathi A; Rao R; Mishra PC; Mallick K; Husain A; Kashyap MK
Mol Cell Biochem; 2021 Feb; 476(2):553-574. PubMed ID: 33029696
[TBL] [Abstract][Full Text] [Related]
9. Structure-based drug repurposing against COVID-19 and emerging infectious diseases: methods, resources and discoveries.
Masoudi-Sobhanzadeh Y; Salemi A; Pourseif MM; Jafari B; Omidi Y; Masoudi-Nejad A
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 33993214
[TBL] [Abstract][Full Text] [Related]
10. Multi-Omics and Artificial Intelligence-Guided Drug Repositioning: Prospects, Challenges, and Lessons Learned from COVID-19.
Cong Y; Endo T
OMICS; 2022 Jul; 26(7):361-371. PubMed ID: 35759424
[TBL] [Abstract][Full Text] [Related]
11. Drugs repurposing for SARS-CoV-2: new insight of COVID-19 druggability.
Debnath SK; Debnath M; Srivastava R; Omri A
Expert Rev Anti Infect Ther; 2022 Sep; 20(9):1187-1204. PubMed ID: 35615888
[TBL] [Abstract][Full Text] [Related]
12. A critical overview of computational approaches employed for COVID-19 drug discovery.
Muratov EN; Amaro R; Andrade CH; Brown N; Ekins S; Fourches D; Isayev O; Kozakov D; Medina-Franco JL; Merz KM; Oprea TI; Poroikov V; Schneider G; Todd MH; Varnek A; Winkler DA; Zakharov AV; Cherkasov A; Tropsha A
Chem Soc Rev; 2021 Aug; 50(16):9121-9151. PubMed ID: 34212944
[TBL] [Abstract][Full Text] [Related]
13. COVID-19: Discovery, diagnostics and drug development.
Asselah T; Durantel D; Pasmant E; Lau G; Schinazi RF
J Hepatol; 2021 Jan; 74(1):168-184. PubMed ID: 33038433
[TBL] [Abstract][Full Text] [Related]
14. Application of artificial intelligence and machine learning in drug repurposing.
Ghandikota SK; Jegga AG
Prog Mol Biol Transl Sci; 2024; 205():171-211. PubMed ID: 38789178
[TBL] [Abstract][Full Text] [Related]
15. Repurposed drugs and nutraceuticals targeting envelope protein: A possible therapeutic strategy against COVID-19.
Das G; Das T; Chowdhury N; Chatterjee D; Bagchi A; Ghosh Z
Genomics; 2021 Jan; 113(1 Pt 2):1129-1140. PubMed ID: 33189776
[TBL] [Abstract][Full Text] [Related]
16. Targeting SARS-CoV-2 Main Protease: A Computational Drug Repurposing Study.
Baby K; Maity S; Mehta CH; Suresh A; Nayak UY; Nayak Y
Arch Med Res; 2021 Jan; 52(1):38-47. PubMed ID: 32962867
[TBL] [Abstract][Full Text] [Related]
17. Therapeutics for COVID-19: from computation to practices-where we are, where we are heading to.
Ojha PK; Kar S; Krishna JG; Roy K; Leszczynski J
Mol Divers; 2021 Feb; 25(1):625-659. PubMed ID: 32880078
[TBL] [Abstract][Full Text] [Related]
18. Identification of candidate repurposable drugs to combat COVID-19 using a signature-based approach.
O'Donovan SM; Imami A; Eby H; Henkel ND; Creeden JF; Asah S; Zhang X; Wu X; Alnafisah R; Taylor RT; Reigle J; Thorman A; Shamsaei B; Meller J; McCullumsmith RE
Sci Rep; 2021 Feb; 11(1):4495. PubMed ID: 33627767
[TBL] [Abstract][Full Text] [Related]
19. Viral pandemic preparedness: A pluripotent stem cell-based machine-learning platform for simulating SARS-CoV-2 infection to enable drug discovery and repurposing.
Esmail S; Danter W
Stem Cells Transl Med; 2021 Feb; 10(2):239-250. PubMed ID: 32961040
[TBL] [Abstract][Full Text] [Related]
20. Artificial Intelligence against COVID-19 Pandemic: A Comprehensive Insight.
Equbal A; Masood S; Equbal I; Ahmad S; Khan NZ; Khan ZA
Curr Med Imaging; 2022; 19(1):1-18. PubMed ID: 34607548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
